PET Measurement of rCBF in the presence of a neurochemical tracer

Journal of Neuroscience Methods

Volumn 132, Issue 2, 2004, Pages 199-208

  Converse, Alexander K ^a   Barnhart, Todd E ^b   Dabbs, Kevin A ^b   DeJesus, Onofre T ^b   Larson, Julie A ^c   Nickles, Robert J ^b   Schneider, Mary L ^c   Roberts, Andrew D ^b  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

^b UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^c UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

Dopamine release; Neuromodulation; 11C raclopride

Indexed keywords

DOPAMINE 2 RECEPTOR BLOCKING AGENT; FALLYPRIDE F 18; FLUORINE 18; FLUORINE DERIVATIVE; FLUOROMETHANE F 17; ISOFLURANE; TRACER; UNCLASSIFIED DRUG;

ANESTHESIA; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN BLOOD FLOW; CONTROLLED STUDY; CORRELATION ANALYSIS; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RHESUS MONKEY; SIGNAL TRANSDUCTION;

EID: 0346997976     PISSN: 01650270     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jneumeth.2003.09.006     Document Type: Article

References (34)

1. Breier A., Su T.P., Saunders R., Carson R.E., Kolachana B.S., de Bartolomeis A.et al. Schizophrenia is associated with elevated amphetamine-induced synaptic dopamine concentrations: evidence from a novel positron emission tomography method. Proc. Natl. Acad. Sci. USA. 94:1997;2569-2574.
2. Carson R.E., Breier A., deBartolomeis A., Saunders R.C., Su T.P., Schmall B.et al. Quantification of amphetamine-induced changes in [C-11]raclopride binding with continuous infusion. J. Cereb. Blood Flow Metab. 17:1997;437-447.
3. Carson R.E., Lang L., Wu Y., Ma Y., Der M.G., Herscovitch P.et al. PET evaluation of two F-18-labeled 5-HT1A antagonists with intermediate affinity. J. Nucl. Med. 42(Suppl.):2001;395.
4. 18F ]fallypride in nonhuman primates Synapse. 38:2000;71-79.
5. Dabbs K.A., Converse A.K., Barnhart T.E., Dick D.W., Larson J., Nickles R.J.et al. Visual activation using F-17-fluoromethane in rhesus monkey. J. Nucl. Med. 42(Suppl.):2001;934.
6. de la Fuente-Fernández R., Ruth T.J., Sossi V., Schulzer M., Calne D.B., Stoessl A.J. Expectation and dopamine release: mechanism of the placebo effect in Parkinson's disease. Science. 293:2001;1164-1166.
7. 99mTc brain SPECT J. Nucl. Med. 42:2001;300-308.
8. Gatley S.J., Gifford A.N., Carroll F.I., Volkow N.D. Sensitivity of binding of high-affinity dopamine receptor radioligands to increased synaptic dopamine. Synapse. 38:2000;483-488.
9. Glatting G., Nosske J., Henkel K., Neumaier B., Karitzky J., Karcher K. et al. Assessment of the radiation exposure of patients undergoing a C-11-raclopride-PET investigation. J. Nucl. Med. 42(Suppl.):2001;1038.
10. Huang S.C., Carson R.E., Hoffman E.J., Kuhl D.E., Phelps M.E. An investigation of a double-tracer technique for positron computerized tomography. J. Nucl. Med. 23:1982;816-822.
11. Kearfott K.J. Feasibility of simultaneous and sequentially administered dual tracer protocols for measurement of regional cerebral haematocrit using positron emission tomography. Phys. Med. Biol. 35:1990;249-258.
12. Kety S.S. Theory of blood-tissue exchange and its application to measurement of blood flow. Methods Med. Res. 8:1960;223-227.
13. Koepp M.J., Gunn R.N., Lawrence A.D., Cunningham V.J., Dagher A., Jones T.et al. Evidence for striatal dopamine release during a video game. Nature. 393:1998;266-268.
14. Koeppe RA. 2003, personal communication.
15. Koeppe R.A., Holden J.E., Polcyn R.E., Nickles R.J., Hutchins G.D., Weese J.L. Quantitation of local cerebral blood flow and partition coefficient without arterial sampling-theory and validation. J. Cereb. Blood Flow Metab. 5:1985;214-223.
16. 11C ]tracer single-acquisition positron emission tomography studies J. Cereb. Blood Flow Metab. 21:2001;1480-1492.
17. Laruelle M. Imaging synaptic neurotransmission with in vivo binding competition techniques: a critical review. J. Cereb. Blood Flow Metab. 20:2000;423-451.
18. Laruelle M., Huang Y. Vulnerability of positron emission tomography radiotracers to endogenous competition: new insights. Q. J. Nucl. Med. 45:2001;124-138.
19. Leggett R.W., Williams L.R. A proposed blood circulation model for Reference Man. Health Phys. 69:1995;187-201.
20. Lightfoot EN. Scaling and dimensional analysis in biological systems. In: Transport phenomena and living systems: biomedical aspects of momentum and mass transport. New York: Wiley; 1974. p. 347-57.
21. Logan J., Fowler J.S., Volkow N.D., Wang G.J., Ding Y.S., Alexoff D.L. Distribution volume ratios without blood sampling from graphical analysis of PET data. J. Cereb. Blood Flow Metab. 16:1996;834-840.
22. 11C ]raclopride binding in the brain: model simulations and kinetic analysis of PET data J. Cereb. Blood Flow Metab. 14:1994;995-1010.
23. Meyer-Lindenberg A., Miletich R.S., Kohn P.D., Esposito G., Carson R.E., Quarantelli M.et al. Reduced prefrontal activity predicts exaggerated striatal dopaminergic function in schizophrenia. Nat. Neurosci. 5:2002;267-271.
24. 18F -fallypride in nonhuman primates using positron emission tomography Synapse. 27:1997;1-13.
25. Press WH, Teukolsky SA, Vetterling WT, Flannery BP. Confidence limits on estimated model parameters. In: Numerical recipes in C++. Cambridge: Cambridge University Press; 2002a. p. 694-704.
26. Press WH, Teukolsky SA, Vetterling WT, Flannery BP. Downhill simplex method in multidimensions. In: Numerical recipes in C++. Cambridge: Cambridge University Press; 2002b. p. 413-7.
27. 15O . Part II. Implementation and validation J. Nucl. Med. 24:1983;790-798.
28. 3 [abstract] J. Nucl. Med. 42(Suppl. S):2001;1044.
29. Slates R.B., Farahani K., Shao Y.P., Marsden P.K., Taylor J., Summers P.E.et al. A study of artefacts in simultaneous PET and MR imaging using a prototype MR compatible PET scanner. Phys. Med. Biol. 44:1999;2015-2027.
30. Snyder WS, Cook MJ, Nasset ES, Karhausen LR, Howells GP, Tipton IH. International Commission on Radiological Protection No. 23: Report of the Task Group on Reference Man, Oxford: Pergamon Press; 1975.
31. Sunderland J.J., Nickles R.J. Acceptance testing of the CTI 933/04 ECAT scanner. J. Nucl. Med. 29(Suppl.):1988;880.
32. Tani Y., Ishihara T., Kanai T., Ohno T., Andersson J., Lilja A.et al. Effects of 6R-L-erythro-5,6,7,8-tetrahydrobiopterin on the dopaminergic and cholinergic receptors as evaluated by positron emission tomography in the rhesus monkey. J. Neural Trans. [Gen Sect]. 102:1995;189-208.
33. 11C ]raclopride in the human brain Synapse. 16:1994;255-262.
34. 18F -MPPF in the rat hippocampus: kinetic beta measurements combined with microdialysis J. Neurochem. 80:2002;278-286.